Literature DB >> 26089623

Correlations of Insulin Resistance and Serum Testosterone Levels with LH:FSH Ratio and Oxidative Stress in Women with Functional Ovarian Hyperandrogenism.

S Suresh1, T Vijayakumar2.   

Abstract

Functional ovarian hyperandrogenism (FOH) is a form of polycystic ovary syndrome (PCOS) characterized by elevated circulating levels of androgens derived from the ovary. Insulin resistance (IR) is the most common etiological factor in women with FOH. IR causes the generation of increased oxidative stress (OS) and diminished antioxidant status. OS is directly correlated with both IR and testosterone levels, which consequently contribute to endocrine and biochemical alterations in FOH women. In the current study, elevations in total testosterone, free testosterone and luteinizing hormone (LH) levels accompanied by a decrease in follicle stimulating hormone (FSH) level leading to higher LH:FSH ratio were the prominent endocrine changes observed in women with FOH. A significant increase in fasting blood levels of glucose and insulin, as well as an elevated IR were also seen in FOH women, as compared to their age matched controls. Women with FOH have higher pro-oxidant and lower anti-oxidant levels in blood than their age matched controls. In FOH women, elevations in LH:FSH ratio and OS are correlated more with hyperandrogenemia than with IR. Of the androgens, free rather than total testosterone has better positive correlations with elevated LH:FSH ratio and OS, and hence, the former is a better predictive marker for the development of biochemical PCOS in women with FOH.

Entities:  

Keywords:  Functional ovarian hyperandrogenism; Insulin resistance; LH:FSH ratio; Oxidative stress; Polycystic ovary syndrome; Total and free testosterone

Year:  2014        PMID: 26089623      PMCID: PMC4469060          DOI: 10.1007/s12291-014-0447-z

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  23 in total

1.  Standardization of hormonal assays for the 21st century.

Authors:  Leonard Wartofsky; David J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2010-12       Impact factor: 5.958

Review 2.  Assays for insulin, proinsulin(s) and C-peptide.

Authors:  P M Clark
Journal:  Ann Clin Biochem       Date:  1999-09       Impact factor: 2.057

3.  Diagnostic criteria for polycystic ovary syndrome: a reappraisal.

Authors:  Ricardo Azziz
Journal:  Fertil Steril       Date:  2005-05       Impact factor: 7.329

4.  Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.

Authors:  M Emoto; Y Nishizawa; K Maekawa; Y Hiura; H Kanda; T Kawagishi; T Shoji; Y Okuno; H Morii
Journal:  Diabetes Care       Date:  1999-05       Impact factor: 19.112

Review 5.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

6.  Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome.

Authors:  Robert P Kauffman; Vicki M Baker; Pamela DiMarino; V Daniel Castracane
Journal:  Fertil Steril       Date:  2006-04       Impact factor: 7.329

Review 7.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

Review 8.  Androgens and polycystic ovary syndrome.

Authors:  Vicki Nisenblat; Robert J Norman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-06       Impact factor: 3.243

9.  Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome.

Authors:  Naci Kemal Kuşçu; Ahmet Var
Journal:  Acta Obstet Gynecol Scand       Date:  2009       Impact factor: 3.636

Review 10.  Role of oxidative stress in female reproduction.

Authors:  Ashok Agarwal; Sajal Gupta; Rakesh K Sharma
Journal:  Reprod Biol Endocrinol       Date:  2005-07-14       Impact factor: 5.211

View more
  3 in total

1.  Polycystic Ovary Syndrome Phenotype D Versus Functional Hypothalamic Amenorrhea With Polycystic Ovarian Morphology: A Retrospective Study About a Frequent Differential Diagnosis.

Authors:  Klara Beitl; Didier Dewailly; Rudolf Seemann; Marlene Hager; Jakob Bünker; Daniel Mayrhofer; Iris Holzer; Johannes Ott
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-02       Impact factor: 6.055

2.  Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy.

Authors:  Kui Yao; Ce Bian; Xia Zhao
Journal:  Exp Ther Med       Date:  2017-06-22       Impact factor: 2.447

3.  Evaluation of Changes in Levels of Hyperandrogenism, Hirsutism and Menstrual Regulation After a Period of Aquatic High Intensity Interval Training in Women with Polycystic Ovary Syndrome.

Authors:  Zeinab Samadi; Effat Bambaeichi; Mahboubeh Valiani; Zahra Shahshahan
Journal:  Int J Prev Med       Date:  2019-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.